| 07/17/2026 2:09 PM | CONMED (816956) Issuer Gallagher John E (1628991) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 2:05 PM | CONMED (816956) Issuer Gallagher John E (1628991) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/02/2026 4:12 PM | CONMED (816956) Issuer Mirviss Jeffrey B. (1566094) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:15 PM | CONMED (816956) Issuer Martin Celine Christine (2092680) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 4:06 PM | CONMED (816956) Issuer Martin Celine Christine (2092680) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/17/2026 3:49 PM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 3:30 PM | CONMED (816956) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/04/2026 6:30 AM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/03/2026 3:17 PM | CONMED (816956) Issuer Kelderman Kim (1739054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 3:18 PM | CONMED (816956) Issuer Council LaVerne H (1788616) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 11:30 AM | CONMED (816956) Issuer Lockwood Kimberly (2136158) Reporting | Form 3/A | |
Get the Latest News and Ratings for CNMD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/03/2026 8:15 AM | CONMED (816956) Issuer Lockwood Kimberly (2136158) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 06/01/2026 7:31 AM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 8:25 AM | CONMED (816956) Filer | Form SD Specialized Disclosure Report | |
| 05/20/2026 7:30 AM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 8:52 AM | CONMED (816956) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/29/2026 4:36 PM | CONMED (816956) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 3:18 PM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:54 AM | CONMED (816956) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/07/2026 11:27 AM | CONMED (816956) Filer | Form ARS | |
| 04/07/2026 7:50 AM | CONMED (816956) Filer | Form DEFA14A | |
| 04/07/2026 7:23 AM | CONMED (816956) Filer | Form DEF 14A | |
| 03/26/2026 4:41 PM | CONMED (816956) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/18/2026 1:07 PM | CONMED (816956) Issuer Lalomia Brent (1921560) Reporting | Form 4/A | |
| 03/18/2026 12:53 PM | CONMED (816956) Issuer SHAGORY PETER K (1398627) Reporting | Form 4/A | |
| 03/18/2026 12:55 PM | CONMED (816956) Issuer Ferrell John D. (1980620) Reporting | Form 4/A | |
| 03/18/2026 12:58 PM | CONMED (816956) Issuer Foust Hollie K (2043157) Reporting | Form 4/A | |
| 03/18/2026 1:04 PM | CONMED (816956) Issuer Schabacker Matthew (2066553) Reporting | Form 4/A | |
| 03/13/2026 3:01 PM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 2:47 PM | Beyer Pat (1627985) Reporting CONMED (816956) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 2:50 PM | CONMED (816956) Issuer Moller Andrew James (2054340) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 2:52 PM | CONMED (816956) Issuer Foust Hollie K (2043157) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 2:54 PM | CONMED (816956) Issuer Lalomia Brent (1921560) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 2:57 PM | CONMED (816956) Issuer SHAGORY PETER K (1398627) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:23 AM | CONMED (816956) Issuer Kaye Mark (1748691) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 10:01 AM | CONMED (816956) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 01/12/2026 8:00 AM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 4:00 PM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 10:29 AM | CONMED (816956) Issuer Lalomia Brent (1921560) Reporting | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 12/05/2025 7:09 AM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 12:18 PM | CONMED (816956) Issuer Glaze Richard (2025615) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
A $382 trillion migration and the position no one is talking about (Ad) Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.'
Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move. Click here to see the full research and the position name |
| 11/21/2025 2:39 PM | CONMED (816956) Issuer Glaze Richard (2025615) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 8:40 AM | CONMED (816956) Subject Glaze Richard (2025615) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 9:29 AM | Capital Research Global Investors (1422848) Filed by CONMED (816956) Subject | Form SCHEDULE 13G/A | |
| 11/06/2025 11:39 AM | CONMED (816956) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 8:42 AM | CONMED (816956) Subject Garner Todd W (1726884) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2025 10:06 AM | CONMED (816956) Issuer Farkas Charles (1615538) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/12/2025 12:58 PM | CONMED (816956) Subject Farkas Charles (1615538) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/09/2025 3:11 PM | CONMED (816956) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/09/2025 3:13 PM | CONMED (816956) Issuer Kelderman Kim (1739054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 12:12 PM | CONMED (816956) Issuer Kelderman Kim (1739054) Reporting | Form 3 Initial statement of beneficial ownership of securities | |